Figure 4. Heatmap of altered genes involved in the activated signaling pathways of the eight LAR-TNBC patients. Panels display the involvement of the known genomic alterations (A-D), possibly damaging VUS (B-E) or both (C-F) in modulating the signaling pathways reported in Figures 3 and 4. Each gene is indicated with a different color.
